Donate
Email Password
Not a member? Sign Up   Forgot password?
Business and Economics Education Environment Health Care California
Home
About PRI
My PRI
Contact
Search
Policy Research Areas
Events
Publications
Press Room
PRI Blog
Jobs Internships
Scholars
Staff
Book Store
Policy Cast
Upcoming Events
WSJ's Stephen Moore Book Signing Luncheon-Rescheduled for December 17
12.17.2012 12:00:00 PM
Who's the Fairest of Them All?: The Truth About Opportunity, ... 
More

Recent Events
Victor Davis Hanson Orange County Luncheon December 5, 2012
12.5.2012 12:00:00 PM

Post Election: A Roadmap for America's Future

 More

Post Election Analysis with George F. Will & Special Award Presentation to Sal Khan of the Khan Academy
11.9.2012 6:00:00 PM

Pacific Research Institute Annual Gala Dinner

 More

Reading Law: The Interpretation of Legal Texts
10.19.2012 5:00:00 PM
Author Book Signing and Reception with U.S. Supreme Court Justice ... More

Opinion Journal Federation
Town Hall silver partner
Lawsuit abuse victims project
Health Care PRESS ROOM Archive
Jaundiced View Excludes Idea of Charitable Acts
Submitted by Sally C. Pipes on 7.23.2004

Sir, In her seething column "Big pharma is a two-faced friend" (July 19), Marcia Angell is furious at Pfizer for giving discount drugs to uninsured Americans. Apparently, offering cheaper drugs to low-income people is nothing but a cynical public relations ploy by the pharmaceutical industry.

Consumers Wind Up Victims Of Drug-Importers' Schemes
Submitted by Sally C. Pipes on 7.20.2004

Say what you will about the noise and inconvenience created by the East Coast cicadas. At least they disappear for 17 years. Here in California we have "consumer" leftists, who sadly do not depart even for 17 nanoseconds. Their noisemaking is constant and eternal.

Saying No to Foreign Drugs
Submitted by Sally C. Pipes on 7.1.2004

In this season of the campaign promises, pandering, and appeals to high principle, let's be candid: The process of wealth redistribution through the institutions of democratic politics combines all three beautifully. The latest manifestation of this art form is the current drive in Congress to facilitate the importation of "cheap" pharmaceuticals into the U.S. from Canada (and a number of other nations). This will purportedly reduce U.S. drug costs sharply, with no adverse effects upon future drug development or safety.

Total Records: 3
Within Health Care
Browse by
Recent Publications
Health Care Blog Archive
Powered by eResources